Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT03127995

Active, not recruiting

Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence (HYPOG-01)

Breast Cancer Female
NCT06248918

Enrolling by invitation

Nurse-led Physical Activity Program Among Breast Cancer Survivors (WATSOCPAP)

Health Behavior | Breast Cancer Female | Survivorship
NCT03679559

Completed

Exercise in Improving Health and Quality of Life in Breast Cancer Survivors

Invasive Breast Carcinoma
NCT05444725

Completed

Investigating Barriers for Decision Making in a Danish Breast Cancer Screening Context

Breast Cancer Female | Decision Making | Mammography Screening | Information Seeking Behavior
NCT02927249

Terminated

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Node Positive HER2 Negative Breast Cancer
NCT01934478

Completed

Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
NCT05484180

Completed

The Effect of Guided Imagery Based on the Health Promotion Model on the Quality of Life in Breast Cancer Patients

Breast Cancer Female
NCT05203029

Completed

Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety/Depression Levels in Breast Cancer

Breast Cancer Survivors
NCT03787303

Terminated

Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma (B-TREUH)

Metastatic Breast Cancer | Thyroid Dysfunction
NCT03585218

Completed

Women With Breast Cancer Undergoing Chemotherapy: Implications in Quality of Life

Breast Cancer Female
NCT04337736

Completed

Effects of Physical Exercise on Cardio-vascular Efficiency and Quality of Life in Breast Cancer Survivors

Breast Cancer Female
NCT01205685

Terminated

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

Hormone-sensitive Metastatic Breast Cancer
NCT07460752

Not yet recruiting

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Hormone Receptor-Positive Breast Carcinoma
NCT06823440

Recruiting

Prevention of CIPN Using Compressive Therapy (CIPN)

CIPN in Adjuvant Breast Cancer Patients
NCT04858516

Not yet recruiting

Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer

Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
NCT00897702

Completed

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

Breast Cancer
NCT04024436

Terminated

A Study of TAS-120 in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High Amplification
NCT06183164

Completed

Awareness Based Stress Reduction Program Applied to Breast Cancer Patients Receiving Chemotherapy (Mindfulness)

Breast Cancer Patients Receiving Chemotherapy
NCT05423730

Completed

Alcohol and Breast Cancer (ABC) Trial

Breast Cancer | Aromatase Inhibitors | ER+ Breast Cancer
NCT04305236

Terminated

Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer

Breast Neoplasm | Hormone Receptor Positive Breast Carcinoma
NCT03427450

Completed

Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System (HOMING)

Healthy Volunteers | Breast Cancer, Metastatic
NCT05052437

Completed

PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer

Advanced and Metastatic Breast Cancer
NCT04330339

Completed

Prolonged Nightly Fasting in Breast Cancer Survivors

Breast Cancer | Breast Cancer Recurrent | Fasting | Survivorship
NCT05100914

Completed

Evaluation of the Effects of the Couple-based Family Nursing for Women With Breast Cancer

Breast Cancer | Mastectomy | Women | Breast-Conserving Surgery
NCT03059875

Active, not recruiting

Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter)

Surgery | Female Breast Cancer | 75 Years Old and More
NCT02347449

Completed

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

Hormone Receptor Positive Malignant Neoplasm of Breast
NCT04456855

Unknown

Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients (SYSBTC-001)

Advanced Breast Cancer | Surgery | Breast Neoplasm Female
NCT04276337

Active, not recruiting

Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy

HER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNA
NCT01927081

Completed

Self-management Interventions for Advanced Breast Cancer

Advanced Breast Cancer Stage IV
NCT03111615

Unknown

HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer (HOTBreast)

Breast Cancer Female | Hormone Dependent Neoplasms
NCT00888589

Completed

Detection of Aggressive Breast Tumors Using Tc-99m-NC100692

Breast Cancer
NCT01711502

Completed

Epidemiology and Management of Metastatic Breast Cancer

Breast Cancer Nos Metastatic Recurrent
NCT07121244

Recruiting

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer | Metastatic Hormone Receptor Positive Breast Cancer
NCT06882499

Not yet recruiting

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II (AVATARII)

Metastatic Breast Cancer | Breast Cancer, Metastatic
NCT06679387

Recruiting

"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT05866432

Recruiting

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases (TUXEDO-2)

Breast Cancer Stage IV
NCT03786094

Terminated

Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer (FORTRESS)

Metastatic Breast Cancer | Locally Recurrent Breast Cancer
NCT01894451

Completed

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Inflammatory Breast Carcinoma
NCT01986569

Completed

Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer
NCT00307229

Completed

Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

Metastatic Breast Cancer | Recurrent Breast Cancer
NCT06617455

Terminated

Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial (VEnT)

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Localized Breast Carcinoma
NCT00390455

Completed

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7
NCT06309459

Completed

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma

Triple Negative Breast Cancer | Carbonic Anhydrase IX
NCT05503108

Suspended

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer (DIRECT-2)

HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response Rate
NCT05727813

Completed

To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)

Stage I Breast Cancer | Cancer, Treatment-Related | Systemic Inflammatory Response | Tumor of Breast
NCT02404051

Unknown

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer (FEVEX)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant Neoplasm
NCT06957886

Recruiting

A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer

HER2-low Breast Cancer
NCT06747338

Recruiting

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer (Neo-Healer)

Early or Locally Advanced HER2-positive Breast Cancer
NCT06578299

Not yet recruiting

Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer

Breast Cancer Stage IV
NCT06460974

Not yet recruiting

The Effect of Stress Ball Application on Stress, Anxiety and Comfort During Chemotherapy in Women With Breast Cancer

Patients With Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations